BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 996350)

  • 1. [Immunology in cancerology laryngo-pharingeal].
    Clemente JM; López-Campos JL
    Rev Esp Otoneurooftalmol Neurocir; 1976; 34(198):65-82. PubMed ID: 996350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Values of antiviral antibodies in the plasma of the patients with otorhinolaryngologic cancer].
    Takasu T; Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Jul; 73(7 Suppl):Suppl:1074-5. PubMed ID: 5466792
    [No Abstract]   [Full Text] [Related]  

  • 4. The gordian knot of tumour immunology.
    Amlot P
    Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune functions in cancers of the upper respiratory and digestive tracts].
    Follézou JY; Bayssas M; Provost MA; Fridman WH; Dumont J; Point D; Brugère J
    Nouv Presse Med; 1978 Oct; 7(37):3368. PubMed ID: 733515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological changes with prognostic significance in malignant pharyngo-laryngeal tumors].
    Suceava I; Simu G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):53-8. PubMed ID: 6454219
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
    Ghoneum M; Gill G; Perry L
    Laryngoscope; 1986 Nov; 96(11):1300. PubMed ID: 3773632
    [No Abstract]   [Full Text] [Related]  

  • 9. Why does a tumor grow.
    Ablin RJ
    Allergol Immunopathol (Madr); 1976; 4(6):449-60. PubMed ID: 1016534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of immunoglobulin A in patients with oral and laryngeal malignancies].
    Michalski H; Storch H; Brandl R; Fritsche T
    Stomatol DDR; 1981 Jun; 31(6):413-9. PubMed ID: 6949376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological surveillance of otorhinolaryngological cancers].
    Bagarry D; Favre R; Imbert J; Jausseran M; Meyer G; D'Istria JC; Serafino X
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Dec; 23(10):852-9. PubMed ID: 4282092
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemo-immunotherapy and immunological study in carcinoma of larynx and laryngopharynx.
    Purohit JP; Dayal D; Kapoor AK; Khan IU
    J Indian Med Assoc; 1991 Aug; 89(8):219-21. PubMed ID: 1748797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
    Finn OJ
    Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of repeated IgE titre determinations for the early diagnosis of tumour recurrence in the otolaryngological area (author's transl)].
    Horak F; Hussarek-Heinlein M
    Wien Klin Wochenschr; 1976 Oct; 88(20):657-60. PubMed ID: 997545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of leukocyte adherence ability under the influence of magnetic field in the course of a treatment of patients with laryngeal and pharyngeal carcinoma.
    Cocek A; Hahn A; Ambrus M; Dohnalová A; Jandová A; Pokorný J
    Electromagn Biol Med; 2008; 27(3):277-88. PubMed ID: 18821203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems of tumor immunology and immunotherapy].
    Schmidt CG
    Helv Chir Acta; 1973 Mar; 40(1):77-86. PubMed ID: 4540691
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunological balance in cancerology].
    Serrou B
    Acta Otorinolaryngol Iber Am; 1973; 24(2):121-31. PubMed ID: 4803645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of various immunologic indicators in patients with laryngopharyngeal cancer before and after administration of T-activin].
    Nummaev GM; Drevnina NA
    Vestn Otorinolaringol; 1989; (1):67. PubMed ID: 2785312
    [No Abstract]   [Full Text] [Related]  

  • 19. Second counterpoint: animal tumor models and their relevance to human tumor immunology.
    Herberman RB
    J Biol Response Mod; 1983; 2(3):217-26. PubMed ID: 6644338
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies against laryngeal carcinomas. Preliminary report.
    Cortesina G; Cavallo GP; Macario M; Regina S; Prat M; Bussolati G
    G Batteriol Virol Immunol; 1985; 78(1-6):3-7. PubMed ID: 3915739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.